Arcturus Therapeutics Holdings Inc. (ARCT)

ARCT Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	343.4	347.01	391.88	370.49	462.9	71.35
Cash & Cash Equivalents	343.4	347.01	391.88	370.49	462.9	71.35
Cash Growth	4.71%	-11.45%	5.77%	-19.96%	548.74%	94.37%
Receivables	27.06	32.06	2.76	3.37	2.13	2.18
Other Current Assets	5.34	7.52	8.69	5.1	2.77	0.76
Total Current Assets	375.79	386.59	403.33	378.96	467.79	74.29
Property, Plant & Equipment	41.18	40.93	44.96	11.26	8.56	7.48
Long-Term Investments	1.89	1.89	2.09	2.59	0.11	0.37
Total Long-Term Assets	43.06	42.81	47.05	13.85	8.67	7.85
Total Assets	418.85	429.4	450.39	392.81	476.46	82.14
Accounts Payable	9.14	5.28	7.45	10.06	10.77	5.79
Deferred Revenue	83.31	87.33	48.72	63.41	30.62	23.58
Current Debt	0	0	60.66	22.47	1.25	0
Other Current Liabilities	22.98	-10.62	10.16	3.59	6.88	-8.05
Total Current Liabilities	115.43	81.99	126.98	99.54	49.52	21.32
Long-Term Debt	27.65	25.91	30.22	45.14	17.87	19.85
Other Long-Term Liabilities	11.8	42.99	22.88	19.93	12.51	15.18
Total Long-Term Liabilities	39.45	68.9	53.09	65.07	30.38	35.03
Total Liabilities	154.88	150.89	180.08	164.6	79.9	56.35
Total Debt	27.65	25.91	90.87	67.61	19.12	19.85
Debt Growth	-5.26%	-71.49%	34.41%	253.60%	-3.65%	100.23%
Retained Earnings	-394.68	-367.87	-338.14	-347.49	-143.82	-71.67
Shareholders' Equity	263.97	278.51	270.31	228.21	396.55	25.79
Net Cash / Debt	315.74	321.1	301.01	302.88	443.78	51.51
Net Cash / Debt Growth	5.69%	6.67%	-0.62%	-31.75%	761.57%	92.21%
Net Cash Per Share	11.75	12.06	11.11	11.51	21.86	4.27
Working Capital	260.36	304.6	276.35	279.42	418.27	52.97
Book Value Per Share	9.82	10.46	10.22	8.67	19.53	2.14

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).